47
Participants
Start Date
October 18, 2020
Primary Completion Date
November 28, 2023
Study Completion Date
November 28, 2023
GC4711 +SBRT
15 minute IV Infusion prior to SBRT
Placebo +SBRT
15 minute IV infusion prior to SBRT
Duke University Medical Center, Durham
Gibbs Cancer Center & Research Institute, Spartanburg
IACT Health, Columbus
University Hospitals Cleveland Medical Center, Cleveland
University of Iowa Hospitals and Clinics, Iowa City
Parkland Health and Hospital System, Dallas
The University of Texas Southwestern Medical Center, Dallas
Banner McKee Medical Center, Loveland
Banner MD Anderson Cancer Center at NCMC, Greeley
Cancer Care Northwest, Spokane
Lead Sponsor
Galera Therapeutics, Inc.
INDUSTRY